Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium
Open Access
- 27 June 2024
- journal article
- research article
- Published by Springer Nature in Communications Medicine
- Vol. 4 (1) , 1-10
Abstract
Background: The aetiology of delirium is not known, but pre-existing cognitive impairment is a predisposing factor. Here we explore the associations between delirium and cerebrospinal fluid (CSF) levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), proteins with important roles in both acute injury and chronic neurodegeneration. Methods: Using a 13-plex Discovery Assay®, we quantified CSF levels of 9 MMPs and 4 TIMPs in 280 hip fracture patients (140 with delirium), 107 cognitively unimpaired individuals, and 111 patients with Alzheimer’s disease dementia. The two delirium-free control groups without acute trauma were included to unravel the effects of acute trauma (hip fracture), dementia, and delirium. Results: Here we show that delirium is associated with higher levels of MMP-2, MMP-3, MMP-10, TIMP-1, and TIMP-2; a trend suggests lower levels of TIMP-4 are also associated with delirium. Most delirium patients had pre-existing dementia and low TIMP-4 is the only marker associated with delirium in adjusted analyses. MMP-2, MMP-12, and TIMP-1 levels are clearly higher in the hip fracture patients than in both control groups and several other MMP/TIMPs are impacted by acute trauma or dementia status. Conclusions: Several CSF MMP/TIMPs are significantly associated with delirium in hip fracture patients, but alterations in most of these MMP/TIMPs could likely be explained by acute trauma and/or pre-fracture dementia. Low levels of TIMP-4 appear to be directly associated with delirium, and the role of this marker in delirium pathophysiology should be further explored.Keywords
This publication has 53 references indexed in Scilit:
- Association of Delirium With Long-term Cognitive DeclineJAMA Neurology, 2020
- Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disordersCellular and Molecular Life Sciences, 2019
- CSF biomarkers in delirium: a systematic reviewInternational Journal of Geriatric Psychiatry, 2017
- Proteinases and Matrix Degradation2017
- Delirium detection and monitoring outside the ICUBest Practice & Research Clinical Anaesthesiology, 2012
- Associations of markers of inflammation and coagulation with delirium during critical illnessIntensive Care Medicine, 2012
- Delirium in Elderly Patients and the Risk of Postdischarge Mortality, Institutionalization, and DementiaJAMA, 2010
- Cytokine and Growth Factor Concentration in Cerebrospinal Fluid from Patients with Hydrocephalus Following Endovascular Embolization of Unruptured Aneurysms in Comparison with Other Types of HydrocephalusNeurochemical Research, 2010
- Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinasesAnnals of Neurology, 2003
- Matrix metalloproteinases in neuroinflammationGlia, 2002